IP Verse

Amicus Therapeutics Us, Llc V. Aurobindo Pharma Ltd. - 1:24-cv-01331

Amicus Therapeutics Us, Llc V. Aurobindo Pharma Ltd. (Case No. 1:24-cv-01331), filed on Dec 6, 2024 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:24-cv-01331
Filing Date
Dec 6, 2024
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Amicus Therapeutics US, LLC -
Aurobindo Pharma Ltd. -

Patents Involved

This case involves 3 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US12042489B2
-US12109205B2
-US12042490B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Dec 6, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,042,489; 12,042,490; 12,109,205. (mpb) (Entered: 12/09/2024)PACER Document
Dec 6, 2024Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/10/2026. (mpb) (Entered: 12/09/2024)PACER Document
Dec 6, 2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 12/09/2024)PACER Document
Dec 6, 2024COMPLAINT for Patent Infringement against Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4564408) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(mpb) (Entered: 12/09/2024)PACER Document
Dec 11, 2024STANDING ORDER REGARDING BRIEFING IN ALL CASES. (mws) (Entered: 12/11/2024)PACER Document
Dec 17, 2024STIPULATION TO EXTEND TIME for Defendants to Respond to the Complaint to February 6, 2025 - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 12/17/2024)PACER Document
Jan 7, 2025Joint MOTION to Consolidate Cases - Case No. 24-cv-1331-CFC into Lead Case No. 22-cv-1461-CJB - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Text of Proposed Order)(Stover, Chad) (Entered: 01/07/2025)PACER Document
Jan 8, 2025ORDER in case 1:22-cv-01461-CJB; granting (10) Motion to Consolidate Cases in case 1:24-cv-01331-CFC. Signed by Judge Colm F. Connolly on 1/8/2025. Associated Cases: 1:24-cv-01331-CFC, 1:22-cv-01461-CJB (mws) (Entered: 01/08/2025)PACER Document
Dec 11, 2024Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)PACER Document
Dec 17, 2024SO ORDERED, re 9 STIPULATION TO EXTEND TIME for Defendants to Respond to the Complaint to February 6, 2025, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Reset Answer Deadlines: Aurobindo Pharma Ltd. answer due 2/6/2025; Aurobindo Pharma USA, Inc. answer due 2/6/2025. Ordered by Judge Colm F. Connolly on 12/17/2024. (kmd)PACER Document
Jan 8, 2025Remark: Case associated with lead case: Create association to 1:22-cv-01461-CJB. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-1461-CJB ONLY. (mws) Modified on 1/31/2025 (mws).PACER Document
Dec 6, 2024Summons Issued as to Aurobindo Pharma Ltd. on 12/6/2024; Aurobindo Pharma USA, Inc. on 12/6/2024. (Attachments: # 1 Summons Issued)(mpb) (Entered: 12/09/2024)Attachment
Dec 6, 2024COMPLAINT for Patent Infringement against Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4564408) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(mpb) (Entered: 12/09/2024)Attachment
Dec 6, 2024COMPLAINT for Patent Infringement against Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4564408) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(mpb) (Entered: 12/09/2024)Attachment
Dec 6, 2024COMPLAINT for Patent Infringement against Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4564408) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(mpb) (Entered: 12/09/2024)Attachment
Dec 6, 2024COMPLAINT for Patent Infringement against Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4564408) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(mpb) (Entered: 12/09/2024)Attachment
Jan 7, 2025Joint MOTION to Consolidate Cases - Case No. 24-cv-1331-CFC into Lead Case No. 22-cv-1461-CJB - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Text of Proposed Order)(Stover, Chad) (Entered: 01/07/2025)Attachment